Thursday, 15 October 2026European Markets

SALMONES CAMANCHAC, Coca-ColaEuropacif, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(VIANEWS) - SALMONES CAMANCHAC (SACAM.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Consumer Defensive sector.

Financial Asset Price Forward Dividend Yield Return on Equity
SALMONES CAMANCHAC (SACAM.OL) kr32.20 11.2% 3.92%
Coca-ColaEuropacif (CCEP.AS) €56.00 3.29% 21.88%
B&S Group (BSGR.AS) €3.69 3.24% 10.7%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. SALMONES CAMANCHAC (SACAM.OL)

11.2% Forward Dividend Yield and 3.92% Return On Equity

Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. The company was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Compañía Pesquera Camanchaca S.A.

Earnings Per Share

As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr1.18.

PE Ratio

SALMONES CAMANCHAC has a trailing twelve months price to earnings ratio of 27.29. Meaning, the purchaser of the share is investing kr27.29 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.92%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SALMONES CAMANCHAC's EBITDA is -763.82.

Moving Average

SALMONES CAMANCHAC's value is under its 50-day moving average of kr34.93 and way under its 200-day moving average of kr40.29.

More news about SALMONES CAMANCHAC.

2. Coca-ColaEuropacif (CCEP.AS)

3.29% Forward Dividend Yield and 21.88% Return On Equity

Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. It offers flavours, mixers, and energy drinks; soft drinks, waters, enhanced water, and isotonic drinks; and ready-to-drink tea and coffee, juices, and other drinks. The company provides its products under the Coca-Cola, Diet Coke, Coca-Cola Zero Sugar, Fanta, Sprite, Monster Energy, Coca-Cola Energy, Relentless, nalu, URGE, BURN, Kuli, REIGN, POWERADE, Appletiser, Schweppes, FINLEY, mezzo mix, Royal Bliss, Lift, Vio SCHORLE, Coca-Cola Signature Mixers, NORDIC MIST, smartwater, Chaudfontaine, AQUARIUS, VILAS del Turbon, BONAQUA, Apollinaris, Krystal, Honest, Costa Coffee, Fuzetea, CHAQWA, NESTEA, Capri-Sun, Oasis, Minute Maid, MER, and Tropico brands. In addition, it engages in the bottling and other operations. The company was formerly known as Coca-Cola European Partners plc and changed its name to Coca-Cola Europacific Partners PLC in May 2021. Coca-Cola Europacific Partners PLC was founded in 1904 and is based in Uxbridge, the United Kingdom.

Earnings Per Share

As for profitability, Coca-ColaEuropacif has a trailing twelve months EPS of €3.69.

PE Ratio

Coca-ColaEuropacif has a trailing twelve months price to earnings ratio of 15.18. Meaning, the purchaser of the share is investing €15.18 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.88%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.4%, now sitting on 18.02B for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Nov 16, 2023, the estimated forward annual dividend rate is 1.84 and the estimated forward annual dividend yield is 3.29%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coca-ColaEuropacif's stock is considered to be overbought (>=80).

Volume

Today's last reported volume for Coca-ColaEuropacif is 1804 which is 91% below its average volume of 20056.

More news about Coca-ColaEuropacif.

3. B&S Group (BSGR.AS)

3.24% Forward Dividend Yield and 10.7% Return On Equity

B&S Group S.A. distributes consumer goods worldwide. The company operates through six segments: B&S Liquors, B&S Beauty, B&S Personal Care, B&S Food, B&S Health, and B&S Retail. The B&S Liquors segment distributes branded liquors to wholesalers, consumers, and e-commerce platforms. The B&S Beauty segment distributes and sells branded fragrances and cosmetics to wholesalers, consumers, and e-commerce platforms. The B&S Personal Care segment distributes and sells branded personal and home care products to retailers. The B&S Food segment distributes a range of branded food and beverages products to duty-free, remote, retail, and maritime markets. The B&S Health segment distributes and sells branded medical products and equipment to maritime and remote markets, pharmacies, and travel clinics. The B&S Retail segment offers consumer electronics and multi-category assortments for consumers at travel locations. The company was founded in 1872 and is based in Betzdorf, Luxembourg.

Earnings Per Share

As for profitability, B&S Group has a trailing twelve months EPS of €0.24.

PE Ratio

B&S Group has a trailing twelve months price to earnings ratio of 15.35. Meaning, the purchaser of the share is investing €15.35 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.7%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, B&S Group's stock is considered to be overbought (>=80).

Moving Average

B&S Group's value is above its 50-day moving average of €3.58 and under its 200-day moving average of €3.81.

More news about B&S Group.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com